NeuraCell Facility Supports Neuroscience Research Nationwide
NeuraCell, our non-profit core facility, banks, grows and differentiates induced pluripotent stem cell lines (iPSCs) to study neurodegeneration, neural progenitor cells (NPCs) and retinal pigment epithelium (RPE) cells, as well as three-dimensional neural models called organoids. Many of these methods are technically challenging or require cell lines that are difficult to maintain at high quality. By providing these services to the scientific community, NeuraCell is enhancing the accessibility and speed of research to understand and alleviate neurodegenerative conditions. In 2022, they produced over 22,000 cerebral organoids for researchers at our institute and across the country! Collectively, our staff generated these cellular models, many at multiple developmental time points, for 15 academic and industry labs nationally and internationally. In addition, NeuraCell experts provide core services such as flow cytometry and iCell8 single cell platforms, and develop new technologies to advance stem cell research. Most recently, NeuraCell scientists developed DISC™ Devices to promote high quality pluripotent stem cell culture. These devices work by providing controlled release of growth factors needed to improve stem cell growth and differentiation. FGF2 DISCs™ are now available commercially through StemCultures. They have been a very popular product within the NSCI!
2022 Year-in-Review Series:
Clinical Trial | Publications! | New Funding | Giving Back | Our Team
